Concepedia

Göran Dahl

GD

Statistics

Publications

15

Citations

458

H-Index

13

Active since

2007

Affiliations

AstraZeneca (Sweden)(Current)

Uppsala University

AstraZeneca (United Kingdom)

AstraZeneca (Japan)

Science for Life Laboratory

Göran Dahl is an author at AstraZeneca (Sweden) specializing in life sciences, molecular biology, and enzyme inhibition.

Publications per year

2007–2023

15

Publications

15

Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)

Kevin Doyle, Hans Lönn, Helena Käck et al. · Journal of Medicinal Chemistry · 2016 · 87 citations · Full text

, , +8

A class of highly selective inhibitors bind to an active state of PI3Kγ

Gangadhara Gangadhara, Göran Dahl, Thomas Bohnacker et al. · Nature Chemical Biology · 2019 · 68 citations

, , +14

Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments

Stéphanie M. Guéret, Sasikala Thavam, Rodrigo J. Carbajo et al. · Journal of the American Chemical Society · 2020 · 50 citations · Full text

, , +17

Structure and biophysical characterization of the human full-length neurturin–GFRa2 complex: A role for heparan sulfate in signaling

Jenny Sandmark, Göran Dahl, Linda Öster et al. · Journal of Biological Chemistry · 2018 · 36 citations · Full text

, , +14

Cryo-EM structure of the activated RET signaling complex reveals the importance of its cysteine-rich domain

Janna M. Bigalke, Shintaro Aibara, Robert Roth et al. · Science Advances · 2019 · 35 citations · Full text

, , +17

1–5 of 15